BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 27438521)

  • 1. The Relationship of Vogt-Koyanagi-Harada Syndrome to Ocular Hypertension and Glaucoma.
    Veerappan M; Fleischman D; Ulrich JN; Stinnett SS; Jaffe GJ; Allingham RR
    Ocul Immunol Inflamm; 2017 Dec; 25(6):748-752. PubMed ID: 27438521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, risk factors and management of ocular hypertension or glaucoma in patients with Vogt-Koyanagi-Harada disease.
    Yang P; Wang C; Su G; Pan S; Qin Y; Zhang J; Cao Q; Zhong Z; Zhou C; Wang Y; Kijlstra A
    Br J Ophthalmol; 2021 Dec; 105(12):1678-1682. PubMed ID: 33011689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of angle-closure glaucoma in Vogt-Koyanagi-Harada disease.
    Alvarez-Guzman C; Valdez-Garcia JE; Ruiz-Lozano RE; Rodriguez-Garcia A; Navas-Villar CF; Hartleben-Matkin C; Pedroza-Seres M
    Int Ophthalmol; 2022 Dec; 42(12):3913-3921. PubMed ID: 35789316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vogt-Koyanagi-Harada disease presenting as acute angle closure glaucoma at onset.
    Yang P; Liu X; Zhou H; Guo W; Zhou C; Kijlstra A
    Clin Exp Ophthalmol; 2011; 39(7):639-47. PubMed ID: 22452682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vogt-Koyanagi-Harada syndrome Case report.
    Nicula C; Szabo I
    Rom J Ophthalmol; 2016; 60(3):181-183. PubMed ID: 29450345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl.
    Katsuyama A; Kusuhara S; Awano H; Nagase H; Matsumiya W; Nakamura M
    BMC Ophthalmol; 2019 Aug; 19(1):179. PubMed ID: 31409322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Band-shaped keratopathy in Chinese patients with Vogt-Koyanagi-Harada syndrome.
    Yang P; Sun M
    Cornea; 2011 Dec; 30(12):1336-40. PubMed ID: 21934492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and pre/post-treatment risk factors of glaucoma in Vogt-Koyanagi-Harada disease.
    Yoshitomi S; Harada Y; Hiyama T; Yuasa Y; Hirooka K; Kiuchi Y
    Int Ophthalmol; 2023 Aug; 43(8):2857-2866. PubMed ID: 36929369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM; Hemachandran S; Al-Mezaine HS; Kangave D; Al-Muammar AM
    Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and Management of Glaucoma in Vogt Koyanagi Harada Disease.
    Pandey A; Balekudaru S; Venkatramani DV; George AE; Lingam V; Biswas J
    J Glaucoma; 2016 Aug; 25(8):674-80. PubMed ID: 26967258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral acute angle closure glaucoma as an initial presentation of Vogt-Koyanagi-Harada syndrome: A clinical case report.
    Yuan F; Zhang Y; Yan X
    Eur J Ophthalmol; 2022 Jan; 32(1):NP230-NP234. PubMed ID: 32811185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, Risk Factors and Surgical Outcomes of Cataract among Patients with Vogt-Koyanagi-Harada Disease.
    AlBloushi AF; Alfawaz AM; AlZaid A; Alsalamah AK; Gikandi PW; Abu El-Asrar AM
    Ocul Immunol Inflamm; 2021 Jan; 29(1):128-136. PubMed ID: 31638886
    [No Abstract]   [Full Text] [Related]  

  • 13. The spectrum of Vogt-Koyanagi-Harada disease in Iran.
    Hedayatfar A; Hosseini SM; Karimi N; Falavarjani KG; Badie N; Zameni M; Soheilian M
    Int Ophthalmol; 2018 Apr; 38(2):443-449. PubMed ID: 28260142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vogt-Koyanagi-Harada Syndrome in Brazilian Children.
    Marquezan MC; Nascimento H; Dalbem D; Muccioli C; Belfort R
    Ocul Immunol Inflamm; 2020 Apr; 28(3):402-408. PubMed ID: 31120768
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.
    Abu El-Asrar AM; Al Tamimi M; Hemachandran S; Al-Mezaine HS; Al-Muammar A; Kangave D
    Acta Ophthalmol; 2013 Sep; 91(6):e486-93. PubMed ID: 23575246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome and Prognostic Factors of Phacoemulsification Cataract Surgery in Vogt-Koyanagi-Harada Uveitis.
    Ji Y; Hu K; Li C; Li P; Kijlstra A; Eghrari AO; Lei B; Du L; Wan W; Yang P
    Am J Ophthalmol; 2018 Dec; 196():121-128. PubMed ID: 30194930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spectrum of Vogt-Koyanagi-Harada disease in Turkey: VKH in Turkey.
    Tugal-Tutkun I; Ozyazgan Y; Akova YA; Sullu Y; Akyol N; Soylu M; Kazokoglu H
    Int Ophthalmol; 2007; 27(2-3):117-23. PubMed ID: 16957877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vogt-Koyanagi-Harada syndrome in children: report of a case and review of the literature.
    Berker N; Ozdamar Y; Soykan E; Ozdal P; Ozkan SS
    Ocul Immunol Inflamm; 2007; 15(4):351-7. PubMed ID: 17763135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of pediatric Vogt-Koyanagi- Harada (VKH)-associated panuveitis.
    Soheilian M; Aletaha M; Yazdani S; Dehghan MH; Peyman GA
    Ocul Immunol Inflamm; 2006 Apr; 14(2):91-8. PubMed ID: 16597538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vogt-Koyanagi-Harada Disease in Pre-school Children.
    Sadhu S; Dutta Majumder P; Shah M; George R
    Ocul Immunol Inflamm; 2024 May; 32(4):415-418. PubMed ID: 36084279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.